Patents by Inventor Gert Wensvoort

Gert Wensvoort has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
    Publication number: 20040132014
    Abstract: Composition of matter comprising the causative agent of Mystery Swine Disease, Lelystad Agent, in a live, attenuated, dead, or recombinant form, or a part or component of it. Vaccine compositions and diagnostic kits based thereon. Recombinant nucleic acid comprising a Lelystad Agent-specific nucleotide sequence. Peptides comprising a Lelystad Agent-specific amino acid sequence. Lelystad Agent-specific antibodies.
    Type: Application
    Filed: December 16, 2003
    Publication date: July 8, 2004
    Inventors: Gert Wensvoort, Catharinus Terpstra, Joannes Maria Anthonis Pol, Robertus Jacobus Maria Moormann, Johanna Jacoba Maria Meulenberg
  • Stratification
    Publication number: 20040013661
    Abstract: The invention provides use of a gene-regulatory peptide or functional analogue thereof for the production of a pharmaceutical composition for the treatment of a disease involving an inflammatory condition and/or a counter-inflammatory condition wherein a subject believed to be suffering from the disease is diagnosed to determine inflammatory disease stage, and where treatment is selected depending on the outcome of the determination of disease stage.
    Type: Application
    Filed: April 8, 2003
    Publication date: January 22, 2004
    Inventors: Gert Wensvoort, Nisar Ahmed Khan, Robbert Benner
  • Treatment of burns
    Publication number: 20030224995
    Abstract: The invention relates to the treatment of burn injuries. The invention provides a method for modulating a burn injury in a subject including providing the subject with a gene-regulatory peptide or functional analogue thereof. Furthermore, the invention provides use of an NF-&kgr;B down-regulating peptide or functional analogue thereof for the production of a pharmaceutical composition for the treatment of burn injury of a subject.
    Type: Application
    Filed: April 8, 2003
    Publication date: December 4, 2003
    Inventors: Nisar Ahmed Khan, Gert Wensvoort, Robbert Benner
  • Treatment of neurological disorders
    Publication number: 20030220259
    Abstract: The invention relates to the treatment of the inflammatory component of neurological disorders or so called neuroimmune disorders such as schizophrenia, manic depression and other bipolar disorders, multiple sclerosis, postpartum psychosis and autism. The invention provides a method for modulating a neurological disorder in a subject comprising providing the subject with a gene-regulatory peptide or functional analogue thereof. The invention also provides use of an NF-&kgr;B down-regulating peptide or functional analogue thereof for the production of a pharmaceutical composition for the treatment of a neurological disorder.
    Type: Application
    Filed: April 8, 2003
    Publication date: November 27, 2003
    Inventors: Robbert Benner, Nisar Ahmed Khan, Gert Wensvoort
  • Causative agent of the mystery Swine disease, vaccine compositions and diagnostic kits
    Publication number: 20030118608
    Abstract: Composition of matter comprising the causative agent of Mystery Swine Disease, Lelystad Agent, in a live, attenuated, dead, or recombinant form, or a part or component of it. Vaccine compositions and diagnostic kits based thereon. Recombinant nucleic acid comprising a Lelystad Agent-specific nucleotide sequence. Peptides comprising a Lelystad Agent-specific amino acid sequence. Lelystad Agent-specific antibodies.
    Type: Application
    Filed: August 21, 2002
    Publication date: June 26, 2003
    Inventors: Gert Wensvoort, Catharinus Terpstra, Joannes Maria Anthonis Pol, Robertus Jacobus Maria Moormann, Johanna Jacoba Maria Meulenberg
  • Mystery swine disease diagnostic kits
    Patent number: 6455245
    Abstract: Composition of matter comprising the causative agent of Mystery Swine Disease, Lelystad Agent, in a live, attenuated, dead, or recombinant form, or a part or component of it. Vaccine compositions and diagnostic kits based thereon. Recombinant nucleic acid comprising a Lelystad Agent-specific nucleotide sequence. Peptides comprising a Lelystad Agent-specific amino acid sequence. Lelystad Agent-specific antibodies.
    Type: Grant
    Filed: May 5, 2000
    Date of Patent: September 24, 2002
    Assignee: Stichting Centraal Diergeneeskundig Instituut
    Inventors: Gert Wensvoort, Catharinus Terpstra, Joannes Maria Anthonis Pol, Robertus Jacobus Maria Moormann, Johanna Jacoba Maria Meulenberg
  • Causative agent of the mystery swine disease, vaccine compositions and diagnostics kits
    Patent number: 6197310
    Abstract: Composition of matter comprising the causative agent of Mystery Swine Disease, Lelystad Agent, in a live, attenuated, dead, or recombinant form, or a part or component of it. Vaccine compositions and diagnostic kits based thereon. Recombinant nucleic acid comprising a Lelystad Agent-specific nucleotide sequence. Peptides comprising a Lelystad Agent-specific amino acid sequence. Lelystad Agent-specific antibodies.
    Type: Grant
    Filed: November 13, 1996
    Date of Patent: March 6, 2001
    Assignee: Stichting Centraal Diergeneeskundig Instituut
    Inventors: Gert Wensvoort, Catharinus Terpstra, Joannes Maria Anthonis Pol
  • Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
    Patent number: 5620691
    Abstract: Composition of matter comprising the causative agent of Mystery Swine Disease, Lelystad Agent, in a live, attenuated, dead, or recombinant form, or a part or component of it. Vaccine compositions and diagnostic kits based thereon. Recombinant nucleic acid comprising a Lelystad Agent-specific nucleotide sequence. Peptides comprising a Lelystad Agent-specific amino acid sequence. Lelystad Agent-specific antibodies.
    Type: Grant
    Filed: November 26, 1993
    Date of Patent: April 15, 1997
    Assignee: Stichting Centraal Diergeneeskundig Instituut
    Inventors: Gert Wensvoort, Catharinus Terpstra, Joannes M. A. Pol